tiprankstipranks
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?

153 Followers

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview

24.31%35.59%0.92%39.18%
24.31% Insiders
0.92% Other Institutional Investors
39.18% Public Companies and
Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail and individual investors. Approximately 36.51% of the company’s stock is owned by Institutional Investors, 24.31% is owned by Insiders and 39.18% is owned by Public Companies and Individual Investors.
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail and individual investors. Approximately 36.51% of the company’s stock is owned by Institutional Investors, 24.31% is owned by Insiders and 39.18% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$319354
Dec 31, 2023Sold$1323151
Dec 31, 2023Bought$3142310
Dec 31, 2023Sold$3330092

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,599,079Institution5.58%101,208,136
2,411,025Institution5.17%93,885,314
2,368,691Institution5.08%92,236,828
2,239,384Institution4.81%87,201,613
912,404Institution1.96%35,529,012
822,813Institution1.77%32,040,338
785,626Institution1.69%30,592,276
667,726Institution1.43%26,001,250
647,300Institution1.39%25,205,862
629,033Institution1.35%24,494,545

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,411,025Institution5.17%93,885,314
2,368,691Institution5.08%92,236,828
2,239,384Institution4.81%87,201,613
912,404Institution1.96%35,529,012
785,626Institution1.69%30,592,276
667,726Institution1.43%26,001,250
647,300Institution1.39%25,205,862
629,033Institution1.35%24,494,545
604,700Institution1.30%23,547,018
484,135Institution1.04%18,852,217

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
232,176Institution0.50%9,040,933
29,336Institution0.06%1,056,683
25,936Institution0.06%943,033
19,327Institution0.04%828,355
10,444Institution0.02%379,744
7,527Institution0.02%293,402
6,300Institution0.01%229,068
2,390Institution<0.01%93,162
1,843Institution<0.01%66,385
1,641Institution<0.01%59,224

FAQ

Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 0.92% of the company's stock is held by institutional investors, 24.31% is held by insiders, and 39.18% is held by retail investors.
    What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.92% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
      What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 39.18% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
        Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
        Richard Driehaus owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis